ReviewAdvances in therapy2019

Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.

Stefano Omboni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.